Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May

    NEXT STORY
    MediciNova Announces Plans to Initiate a Clinical Trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)
    PREV STORY
    KRONOS ADVANCED TECHNOLOGIES INC ANNOUNCES EXCLUSIVE MANUFACTURING AND DISTRIBUTION AGREEMENT FOR A NEW LINE OF AIR DISINFECTION PRODUCTS
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cue Biopharma Announces Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

    CAMBRIDGE, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma™, Inc., (NASDAQ: CUE) an ...

    author_avatar
    NASDAQ Market News

    Tesaro to Announce Fourth Quarter 2015 Financial Results on February 25, 2016

    WALTHAM, Mass., Feb. 11, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its ...

    author_avatar
    NASDAQ Market News

    MediWound Reports Final Positive Results of Phase 2 Clinical Trial of EscharEx for the Debridement of Chronic and Hard-to-Heal Wounds

    YAVNE, Israel, Jan. 31, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated ...

    author_avatar
    NASDAQ Market News